Insights into the mechanisms of lymph node metastasis
暂无分享,去创建一个
[1] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. , 1996, The EMBO journal.
[2] K. Alitalo,et al. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. , 1999, Current topics in microbiology and immunology.
[3] H. Wiley,et al. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. , 2001, Journal of the National Cancer Institute.
[4] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[5] G. Oliver,et al. Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.
[6] Seppo Ylä-Herttuala,et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 , 2001, Nature Medicine.
[7] M. Pepper,et al. Lymphangiogenesis and tumor metastasis: myth or reality? , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] M. Witte,et al. Lymphangiogenesis: mechanisms, significance and clinical implications. , 1997, EXS.
[9] D. B. Rautenfeld,et al. New techniques of demonstrating lymph vessels in skin biopsy specimens and intact skin with the scanning electron microscope , 2004, Archives of Dermatological Research.
[10] Steven A. Stacker,et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.
[11] L. Weis,et al. Lymphogenous and hematogenous metastasis of Lewis lung carcinoma in the mouse , 1987, International journal of cancer.
[12] Karl H. Plate,et al. From angiogenesis to lymphangiogenesis , 2001, Nature Medicine.
[13] B. Copeland,et al. Experimental studies on the spread of cancer in the lymphatic system. II. Absence of a lymphatic supply in carcinoma , 1955, Cancer.
[14] M. Skobe,et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. , 2001, The American journal of pathology.
[15] J. Sleeman,et al. Markers for the lymphatic endothelium: In search of the holy grail? , 2001, Microscopy research and technique.
[16] K. Alitalo,et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis , 1999, British Journal of Cancer.
[17] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases. , 1996, The EMBO journal.
[18] A E Giuliano,et al. Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.
[19] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[20] E. Tschachler,et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. , 1999, The American journal of pathology.
[21] Erkki Ruoslahti,et al. A tumor-homing peptide with a targeting specificity related to lymphatic vessels , 2002, Nature Medicine.
[22] L. Liotta,et al. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.
[23] J. Folkman,et al. Tumoral vascularity as a prognostic factor in cancer. , 1996, Important advances in oncology.
[24] Mark C Kelley,et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.
[25] N Cascinelli,et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] E. Ruoslahti. Specialization of tumour vasculature , 2002, Nature Reviews Cancer.
[27] F. Tanaka,et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. , 2002, Cancer research.
[28] R. D. de Waal,et al. Lymphangiogenesis in malignant tumours: does it occur? , 2001, The Journal of pathology.
[29] F. Hetzel,et al. Lymphatic diameters and radionuclide clearance in a murine melanoma model. , 1997, Archives of surgery.
[30] K. Alitalo,et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. , 1998, The American journal of pathology.
[31] J. Burke,et al. Fine structure of the lymphatic capillary and the adjoining connective tissue area. , 1966, The American journal of anatomy.
[32] L. Williams,et al. Mice Lacking Expression of Secondary Lymphoid Organ Chemokine Have Defects in Lymphocyte Homing and Dendritic Cell Localization , 1999, The Journal of experimental medicine.
[33] A. Bianco,et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer , 1995, Cancer.
[34] A. Recht,et al. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. , 1989, International journal of radiation oncology, biology, physics.
[35] F. Eilber,et al. Soft tissue sarcoma nodal metastases: biologic significance and therapeutic considerations. , 1996, Surgical oncology clinics of North America.
[36] K. Alitalo,et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] Thomas Hawighorst,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.
[38] F. Hetzel,et al. Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas. , 1989, Cancer research.
[39] R. Foster. The biologic and clinical significance of lymphatic metastases in breast cancer. , 1996, Surgical oncology clinics of North America.
[40] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[41] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[42] K. Alitalo,et al. Growth factors regulating lymphatic vessels. , 2000, Current topics in microbiology and immunology.
[43] D. Russell. The Spread of Tumours , 1953 .
[44] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[45] J. M. Yoffey. The regeneration of lymphatics. , 1953, Journal international de chirurgie.
[46] I. Carr. Lymphatic metastasis , 2004, Cancer and Metastasis Reviews.
[47] R. Jain,et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.
[48] F. Hetzel,et al. Development of lymph node and pulmonary metastases after local irradiation and hyperthermia of footpad melanomas , 1991, Clinical & Experimental Metastasis.
[49] R. Germain,et al. Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph Nodes , 2002, Science.
[50] J. Warren. The Results of Operations for the Cure of Cancer of the Breast , 1896 .
[51] M. Schindl,et al. Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[52] A. Harris,et al. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[54] B. Fisher,et al. The interrelationship of hematogenous and lymphatic tumor cell dissemination. , 1966, Surgery, gynecology & obstetrics.
[55] W. Halsted,et al. I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. , 1894, Annals of surgery.
[56] M. Skobe,et al. Lymphatic function, lymphangiogenesis, and cancer metastasis , 2001, Microscopy research and technique.
[57] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[58] G. Haas,et al. Spontaneous regional lymph node metastases of three variants of the B16 melanoma: Relationship to primary tumor size and pulmonary metastas , 1986, Journal of surgical oncology.
[59] L. Orci,et al. Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis , 2001, The EMBO journal.
[60] R K Jain,et al. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. , 1990, Journal of the National Cancer Institute.
[61] F. Hetzel,et al. Lymph flow from murine footpad tumors before and after sublethal hyperthermia. , 1992, Radiation research.
[62] K. Paavonen,et al. Lymphatic versus blood vascular endothelial growth factors and receptors in humans , 2001, Microscopy research and technique.
[63] K. Alitalo,et al. Adenoviral Expression of Vascular Endothelial Growth Factor-C Induces Lymphangiogenesis in the Skin , 2001, Circulation research.
[64] S. Eccles,et al. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. , 2001, Neoplasia.
[65] Dai Fukumura,et al. Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.
[66] M. Karkkainen,et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. , 2001, Cancer research.
[67] R. Jain,et al. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? , 2002, Journal of the National Cancer Institute.
[68] J. Folkman,et al. Lymphangiogenesis New Mechanisms , 2002, Annals of the New York Academy of Sciences.
[69] Peter Carmeliet,et al. Molecular mechanisms of lymphangiogenesis in health and disease. , 2002, Cancer cell.
[70] W. L. McGuire,et al. Prognostic factors for recurrence and survival in human breast cancer , 1987, Breast Cancer Research and Treatment.
[71] T. Veikkola,et al. Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice , 2001, The EMBO journal.
[72] E. R. Clark,et al. Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into the rabbit's ear , 1932 .
[73] L. Weiss. The pathobiology of metastasis within the lymphatic system. , 1996, Surgical Oncology Clinics of North America.
[74] R. vander Zwaag,et al. From Dukes through Jass: pathological prognostic indicators in rectal cancer. , 1994, Human pathology.
[75] R K Jain,et al. Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. , 1996, The American journal of physiology.
[76] D. Jackson,et al. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.
[77] H. Saeki,et al. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. , 1999, Journal of immunology.
[78] K. Kinzler,et al. Genes expressed in human tumor endothelium. , 2000, Science.
[79] P. Hall,et al. Prognostic and predictive factors. , 2004, Methods in molecular medicine.
[80] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[81] K. Alitalo,et al. VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors , 2002, International journal of cancer.
[82] S. Fox,et al. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[83] H. Dvorak,et al. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.
[84] G. Schmid-Schönbein,et al. Microlymphatics and lymph flow. , 1990, Physiological reviews.
[85] M. Ross,et al. The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.
[86] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[87] D. Krag,et al. The gamma-probe-guided resection of radiolabeled primary lymph nodes. , 1996, Surgical oncology clinics of North America.
[88] L. Leak,et al. Lymphangiogenesis in vitro: formation of lymphatic capillary-like channels from confluent monolayers of lymphatic endothelial cells. , 1994, In vitro cellular & developmental biology. Animal.
[89] Mark J. Miller,et al. Two-Photon Imaging of Lymphocyte Motility and Antigen Response in Intact Lymph Node , 2002, Science.
[90] Federica Sallusto,et al. Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production , 2000, The Journal of experimental medicine.
[91] Jeffrey E Gershenwald,et al. Targeting Lymphatic Metastasis , 2002, Science.
[92] R. Zarbo,et al. Microvessels that predict axillary lymph node metastases in patients with breast cancer. , 2000, Archives of surgery.
[93] D L Morton,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.
[94] H. Florey,et al. Proliferation of lymphatics in inflammation , 1937 .
[95] D. Weaver,et al. Minimal-access surgery for staging of malignant melanoma. , 1995, Archives of surgery.
[96] C. V. D. Velde,et al. Lymphatic invasion and metastasis , 1977, Experientia.
[97] R. A. Willis. The Spread of Tumours in the Human Body , 1934, Nature.
[98] K. Alitalo,et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells , 1993, The Journal of experimental medicine.
[99] K. Alitalo,et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. , 2002, Journal of the National Cancer Institute.
[100] I. Weissman,et al. L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.